Spectroscopic study of self-assembly of anti-hepatitis C virus sofosbuvir drug with bio-polymeric nanoparticles for improving the drug release effect.
Autor: | Shawky S; Nanotechnology Center, Chemistry Department, Faculty of Science, Kafrelsheikh University, Kafr El-Sheikh 33516, Egypt; Institute of Nanoscience and Nanotechnology, Kafrelsheikh University, Kafr El-Sheikh 33516, Egypt., El-Shafai NM; Nanotechnology Center, Chemistry Department, Faculty of Science, Kafrelsheikh University, Kafr El-Sheikh 33516, Egypt. Electronic address: nagimohamed2016@gmail.com., El-Mehasseb IM; Nanotechnology Center, Chemistry Department, Faculty of Science, Kafrelsheikh University, Kafr El-Sheikh 33516, Egypt. Electronic address: elmehasseb2@gmail.com., Shoueir KR; Institute of Nanoscience and Nanotechnology, Kafrelsheikh University, Kafr El-Sheikh 33516, Egypt., El-Kemary MA; Institute of Nanoscience and Nanotechnology, Kafrelsheikh University, Kafr El-Sheikh 33516, Egypt. Electronic address: elkemary@yahoo.com. |
---|---|
Jazyk: | angličtina |
Zdroj: | Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy [Spectrochim Acta A Mol Biomol Spectrosc] 2021 Nov 15; Vol. 261, pp. 120008. Date of Electronic Publication: 2021 May 26. |
DOI: | 10.1016/j.saa.2021.120008 |
Abstrakt: | Self-assembly of Sofosbuvir drug (SOF) anti-hepatitis C virus (HCV) with bio-polymeric nanoparticles such as chitosan nanoparticles (Cs NPs) and polyvinyl alcohol nanoparticles (PVA NPs), the novel composites have been characterized successfully by different analysis such as Energy-dispersive X-ray spectroscopy (EDX), Scanning electron microscopy (SEM), UV-Visible spectrophotometer (UV-Vis) and Fourier Transmittance Infrared (FT-IR). The improvement of the Sofosbuvir effect as a result of loading drug on the bio-polymer NPs surface has been detected by the UV-Vis, and fluorescence spectroscopy techniques. The improvement of SOF efficiency was revealed via studying the drug release of SOF from biopolymers NPs surface at pH 7.4, UV-Vis spectra used for the releasing process. The binding constant (K Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. (Copyright © 2021 Elsevier B.V. All rights reserved.) |
Databáze: | MEDLINE |
Externí odkaz: |